Company InMed Pharmaceuticals Inc Canadian Securities Exchange
Equities
IN
CA4576371062
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
BayMedica
100.0
%
| 1 | 100.0 % | 4 | 100.0 % | +279.61% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 1 | 100.0 % | 4 | 100.0 % | +279.61% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Eric Adams
CEO | Chief Executive Officer | 61 | 15/06/16 |
Chief Operating Officer | - | 04/11/18 | |
Colin Clancy
IRC | Investor Relations Contact | - | - |
Gerard Griffin
SAM | Sales & Marketing | - | 31/01/22 |
Eric Hsu
PRN | Corporate Officer/Principal | - | 12/03/18 |
General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Janet Grove
BRD | Director/Board Member | 57 | 10/02/22 |
Eric Adams
CEO | Chief Executive Officer | 61 | 15/06/16 |
Andrew Hull
CHM | Chairman | 61 | 11/09/16 |
Bryan Baldasare
BRD | Director/Board Member | 58 | 11/05/22 |
Nicole Lemerond
BRD | Director/Board Member | 48 | 07/08/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,056,970 | 5,974,441 ( 98.64 %) | 0 | 98.64 % |
Company contact information
InMed Pharmaceuticals, Inc.
815 West Hastings Street Suite 310
V6C 1B4, Vancouver
+604 669 7207
http://www.inmedpharma.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |